A citation-based method for searching scientific literature

Oliver Kloeters, Helmut Friess, Nathalia Giese, Markus W Buechler, Yalcin Cetin, Hasan Kulaksiz. Scand J Gastroenterol 2008
Times Cited: 17



Terry Hyslop, Scott A Waldman. Biomark Med 2013
Times Cited: 12




List of shared articles



Times cited

Antibody drug conjugates under investigation in phase I and phase II clinical trials for gastrointestinal cancer.
Alexis D Leal, Anuradha Krishnamurthy, Lia Head, Wells A Messersmith. Expert Opin Investig Drugs 2018
6

A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase C.
Khaldoun Almhanna, David Wright, Teresa Macarulla Mercade, Jean-Luc Van Laethem, Antonio Cubillo Gracian, Carmen Guillen-Ponce, Jason Faris, Carolina Muriel Lopez, Richard A Hubner, Johanna Bendell,[...]. Invest New Drugs 2017
18

TAK-264 (MLN0264) in Previously Treated Asian Patients with Advanced Gastrointestinal Carcinoma Expressing Guanylyl Cyclase C: Results from an Open-Label, Non-randomized Phase 1 Study.
Yung-Jue Bang, Toshimi Takano, Chia-Chi Lin, Adedigbo Fasanmade, Huyuan Yang, Hadi Danaee, Takayuki Asato, Thea Kalebic, Hui Wang, Toshihiko Doi. Cancer Res Treat 2018
4

Consistent expression of guanylyl cyclase-C in primary and metastatic gastrointestinal cancers.
Hadi Danaee, Thea Kalebic, Timothy Wyant, Matteo Fassan, Claudia Mescoli, Feng Gao, William L Trepicchio, Massimo Rugge. PLoS One 2017
23

Phase I Study of the Investigational Anti-Guanylyl Cyclase Antibody-Drug Conjugate TAK-264 (MLN0264) in Adult Patients with Advanced Gastrointestinal Malignancies.
Khaldoun Almhanna, Thea Kalebic, Cristina Cruz, Jason E Faris, David P Ryan, JungAh Jung, Tim Wyant, Adedigbo A Fasanmade, Wells Messersmith, Jordi Rodon. Clin Cancer Res 2016
25